11/09/2023
Thrilled to Announce the Successful Launch of i.mune TBNK & i.mune Neo in Bangladesh
We're elated to unveil that the highly-anticipated launch of i.mune TBNK and i.mune Neo in Bangladesh was an astounding success! This joint initiative between Oncos Molbiol, Radiant Business Consortium Limited, and Epimune Diagnostics, Germany, sets a new benchmark in the world of diagnostics.
Spanning two action-packed days, the event was held at The Westin on September 8th and Hotel Intercontinental on September 9th, 2023.
Nearly 400 healthcare luminaries across specialties came together to discuss and celebrate groundbreaking innovations in diagnostics.
Our distinguished lineup of speakers were:
Staub, CEO of Epimune GmbH, Germany
Landt, CEO of Tib Mol Biol lab
Prof. M. Sawkat Hassan, Director, Laboratory Science Division, BIRDEM General Hospital
Dr. Sohrab Alam, Director, Oncos Molbiol Ltd
Mr. Md. Abu Shahriar Zahedee, MD of Oncos Molbiol and Executive Director of Radiant Pharmaceuticals Limited, played an instrumental role in orchestrating the event.
Lt. Gen. Sina Ibn Jamali (Retd), MD of Radiant Pharmaceuticals Limited, graced the occasion with his esteemed presence.
Our Chairman, Mr. Nasser Shahrear Zahedee, a celebrated philanthropist and a towering figure in the pharma sector, inspired everyone with his motivational address.
This milestone propels us further in our relentless pursuit of excellence in diagnostics. We're excited for what lies ahead as we continue our mission to transform healthcare and elevate lives.